Conversely, one of the other major effects of IFNγ is upregulation of major histocompatibility class-I (MHC-I) gene expression and therefore in the setting of cancer, increased tumor antigen processing and presentation leading to improved T-cell recognition and cytotoxicity4–8. The gene discussed is IFNG; the disease is cancer.